A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)

Clinical trial NCT02423122 · COMPLETED

Trial details

NCT number

NCT02423122

Sponsor

EIP Pharma Inc

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2015-04-01

Primary completion

2016-07-01

Enrollment

16

View on ClinicalTrials.gov